Skip to main content
Signal8

Cowan Elvia

SEC insider (Form 3/4/5 filer). CIK 0001960048. SVP, Finance & CAO at Vaxcyte, Inc. (PCVX). 32 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in SAN CARLOS, CA.

Companies Cowan Elvia has filed insider reports for

  • Vaxcyte, Inc. (PCVX): Officer, SVP, Finance & CAO
Cowan Elvia profile photo

Cowan Elvia

CIK: 0001960048

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (25.0%)

Position reduction

Option Exercises (M)6 (18.8%)

Derivative conversions

Awards (A)5 (15.6%)

Compensation grants

Other (G, F, J, C, D, …)13 (40.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Vaxcyte, Inc. logo
PCVX

Vaxcyte, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (32 total)

  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Oct 5, 2026
    Exercise
    Direct
    19K shares at avg. $25.92$492K
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Oct 5, 2026
    Sale
    Direct
    19K shares at avg. $86.74$1.6M
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Sep 8, 2026
    Tax Payment
    Direct
    1.3K shares at avg. $60.36$80K
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Sep 2, 2026
    Tax Payment
    Direct
    326 shares at avg. $61.58$20K
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Aug 31, 2026
    Tax Payment
    Direct
    243 shares at avg. $60.74$15K
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Apr 7, 2026
    Exercise
    Direct
    3K shares at avg. $25.92$78K
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Apr 7, 2026
    Sale
    Direct
    3K shares at avg. $60.00$180K
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Mar 17, 2026
    Sale
    Direct
    405 shares at avg. $56.26$23K
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Mar 17, 2026
    Sale
    Direct
    1.5K shares at avg. $55.39$82K
  • Vaxcyte, Inc. logo
    PCVX

    Vaxcyte, Inc.

    Mar 11, 2026
    Sale
    Direct
    2.5K shares at avg. $58.59$146K

1-10 of 32